Consistent with previous reports [5–7], we found enrichment of sgRNA targeting genes associated with both IFN-gamma signalling (Jak1, Jak2, Ifngr2) and TNF signalling (Tnfrsf1a, Fadd) in tumour cells resistant to CAR-T cell killing (Fig. 1C). The gene discussed is JAK1; the disease is neoplasm.